Supplementary figure S8 from Molecular Markers Increase Precision of the European Association of Urology Non–Muscle-Invasive Bladder Cancer Progression Risk Groups

Supplementary figure S8. Progression-free survival curve in patients with EAU high risk tumors of a combination of FGFR3 and GATA2 status. Blue: good status (hypomethylated GATA2 and mutated FGFR3), green; moderate status (either hypermethylated GATA2 and mutated FGFR3 or hypomethylated GATA2 and wild type FGFR3) or red: poor status (hypermethylated GATA2 and wild type FGFR3) compared to a progression free survival curse in all EAU high risk patients. Progressive disease is defined as progression to stage T2 or higher stage disease.